Navigation Links
ExonHit Therapeutics - 2007 Financial Results
Date:3/5/2008

iated since several years by the group.

- Molecular Diagnostic/Genomic Services

In 2006, the Company transferred to bioMerieux a diagnostic panel for the screening of breast cancers in blood. The Company will now continue the projects which have been initiated in common in 2006 and 2007, i.e., blood diagnostic of colon cancer and blood diagnostic of prostate cancer.

In house diagnostic research will also continue for Alzheimer's disease in order to identify, at an early stage, individuals who can develop Alzheimer's disease, and in order to service the existing test to assist the pharmaceutical industry in recruiting homogeneous cohort of patients for clinical trials for new drugs.

In genomic services, the Company, in collaboration with renowned scientists, intends to continue researches on different pathologies to increase the penetration of its new generation of tools, the SpliceArray(TM), in the scientific and medical communities. New biochips, particularly on the Agilent platform, will contribute to fuel the growth of this activity.

- Therapeutics

The strategic collaboration with Allergan will continue with the ambition to validate new pharmacologic programs for clinical trials in man.

In house, Phase 2 study will be realized with EHT0202, in several clinical sites, on 135 patients suffering from Alzheimer's disease, randomized in double-blind. The main objective is to determine the tolerability and safety of the product in an oral administration over a 3 month period, in association with inhibitors of acetylcholinesterase, which is the usual treatment for this disease. The study will also allow the collection of preliminary data on the clinical efficacy of the product, notably on a cognitive and behavioural standpoint.

2007 Consolidated financials results

- Income Statement

Consolidated R&D revenues were EUR 5.3 million in 2007, down 5% compared to EUR 5.6 million in 2006. Total revenues amou
'/>"/>

SOURCE ExonHit Therapeutics SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
2. ExonHit Completes a Prototype to Detect Alzheimers Disease From Blood
3. ExonHit Gets Regulatory Approval to Initiate a Phase 2 Clinical Trial for EHT 0202 in Alzheimers Disease
4. ExonHit and bioMerieux Amend Their Strategic Partnership
5. ExonHit Builds A New Organisation
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
10. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
11. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)...  MiMedx Group, Inc. (NASDAQ: MDXG ), the ... patent-protected processes to develop and market advanced products and ... Medicine, Ophthalmic and Dental sectors of healthcare, announced today ... Annual Canaccord|Genuity Growth Conference in Boston, Massachusetts ... William C. Taylor , President and COO, and ...
(Date:8/3/2015)... Medical, Inc. (Nasdaq: AEMD ), the pioneer in ... announced that it will host its First Quarter Fiscal ... 13, 2015 at 4:30 p.m. Eastern Time. ... fiscal 2016 first quarter results.  A recorded version of ... the call at the Investor Relations portion of the ...
(Date:8/3/2015)... VANCOUVER, BC , Aug. 3, 2015 /PRNewswire/ - RepliCel ... regenerative medicine company focused on the development of autologous cell ... will be presenting at the InvestMNT conference held in ... at 8:15 AM local time. Hall,s presentation will highlight RepliCel,s ... for sale in Europe , clinical data ...
(Date:7/31/2015)... KONG , July 31, 2015 China ... China,s leading provider of cord ... stem cell storage services, today announced that the Company ... the U.S. Securities and Exchange Commission. The filed Form ... ended March 31, 2015. The Form 20-F can be ...
Breaking Biology Technology:MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference 2Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2RepliCel Presenting at InvestMNT Investor Conference in Minneapolis 2China Cord Blood Corporation Files Its Annual Report on Form 20-F 2
... Stem Cell Treatments -- SHENZHEN, China, Sept. 2 /PRNewswire-Asia/ -- ... ... ... first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var ...
... everything from antibacterial socks to medical imaging to ... health and safety risks of these particles also ... and Technology (NIST) have developed a simple process ... certain physical and chemical properties that affect how ...
... ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS... -- YOKOHAMA, Japan, September 1, ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
Cached Biology Technology:New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments 2New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments 3New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments 4New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments 5New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments 6New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments 7New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments 8The perfect nanocube: Precise control of size, shape and composition 2ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 2ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 3ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 4ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 5ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells 6
(Date:7/27/2015)... 27, 2015   Zynx Health ™, the ... improvement solutions, today announced that its ZynxCarebook ... on Android smartphones and tablets. With this expansion, ... can use ZynxCarebook to securely exchange messages and ... care transitions to other care settings, and improve ...
(Date:7/21/2015)... Passwords have proven futile for securing ... U.S. Office of Personnel Management breach. Biometric authentication ... but developers and end-users are concerned about how ... Biometrics-as-a-Service provider HYPR Corp. announced today the general ... party integration. A video overview ...
(Date:7/9/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/98rrmr/biometrics_for ... "Biometrics for Banking; Market & Technology Analysis, Adoption ... offering. The adoption for banking purposes ... the forecast is that by 2020 it will ... in delivering biometric systems to the banking industry. ...
Breaking Biology News(10 mins):Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... Denizens of oceans, lakes and even wet ... intricately patterned, glass-like shells. Curiously, these tiny phytoplankton could ... Diatoms build their hard cell walls by laying down ... key material of the semiconductor industrysilicon. If we can ...
... stem cells from mice, UT Southwestern Medical Center researchers ... importantly, functioning muscle cells in mice afflicted with ... study represents the first time transplanted embryonic stem cells ... in a model of muscular dystrophy. The researchers ...
... in French . , A study led ... between individuals at the DNA level can lead to ... in turn, are responsible for the vast array of ... of the Genome Regulators in Disease (GRID) Project funded ...
Cached Biology News:In diatom, scientists find genes that may level engineering hurdle 2Stem-cell transplantation improves muscles in MD animal model, UT Southwestern researchers report 2Stem-cell transplantation improves muscles in MD animal model, UT Southwestern researchers report 3Tiny genetic differences have huge consequences: McGill researchers 2
... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... "pipette/tip" system ensures utmost accuracy and precision. ...
PA coated Agarose beads LPA Beads...
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding...
Mouse monoclonal antibody to PAEP - progestagen-associated endometrial protein (placental protein 14, pregnancy-associated endometrial alpha-2-globulin, alpha uterine protein)...
Biology Products: